Interferon alfa-2b in the management of chronic granulocytic leukemia.
Bergsagel
D E
DE
Princess Margaret Hospital, University of Toronto, Canada.
D000328:Adult; D000368:Aged; D002066:Busulfan / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D007951:Leukemia, Myeloid / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D010677:Philadelphia Chromosome; D011994:Recombinant Proteins / Q000627:therapeutic use
D007370:Interferon Type I; D011994:Recombinant Proteins; D002066:Busulfan